Optimization of C-5 sterol desaturation

US12018309B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12018309-B2
Application numberUS-201917051610-A
CountryUS
Kind codeB2
Filing dateMay 21, 2019
Priority dateMay 22, 2018
Publication dateJun 25, 2024
Grant dateJun 25, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is related to an improved method for production of 7-dehydrocholesterol (7-DHC), an important intermediate towards biotechnological production of vitamin D3 or derivatives/metabolites thereof. The invention features modified host strains expressing enzymes having improved C-5 sterol 5 desaturase activity and their use in a process for production of vitamin D3 or derivatives and/or metabolites thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A cholesterol-producing yeast cell expressing (i) a heterologous C5-sterol desaturase with at least 90% sequence identity to SEQ ID NO: 2, 4, 6 or 8 and (ii) a heterologous C8-isomerase with at least 90% sequence identity to SEQ ID NO:_14, wherein the yeast cell is capable of producing a sterol mix comprising 7-dehydrocholesterol (7-DHC), lanosterol, and lathosterol, wherein the ratio of 7-DHC to lanosterol and lathosterol combined is at least 5% higher than the ratio of 7-DHC to lanosterol and lathosterol combined in a sterol mix produced by a reference yeast cell that does not express the heterologous C5-sterol desaturase and C8-isomerase. 2. The cholesterol-producing yeast cell according to claim 1 , wherein at least 84% of the sterol mix produced is 7-DHC. 3. The cholesterol-producing yeast cell according to claim 1 , wherein 7-DHC is produced at a ratio to lanosterol of 18 or more. 4. The cholesterol-producing yeast cell according to claim 1 , wherein the heterologous C5-sterol desaturase is from S. cerevisiae, Y. lipolytica, K. lactis, S. pombe, P. pastoris, C. albicans, P. roqueforti, A. nidulans, C. neoformans, M. oryzae, M. acridum , or U. maydis. 5. The cholesterol-producing yeast cell according to claim 1 in which ERG5 and ERG6 are inactivated. 6. The cholesterol-producing yeast cell according to claim 1 , wherein the yeast cell further expresses a heterologous plant or vertebrate sterol 424-reductase. 7. A process for production of 7-DHC, comprising cultivating the yeast cell according to claim 1 under conditions suitable for sterol production. 8. The process according to claim 7 , wherein the 7-DHC is further converted into vitamin D3. 9. The process according to claim 7 , wherein the 7-DHC is further converted into 25-hydroxyvitamin D3. 10. A process for production of a sterol mix, said process comprising cultivating the yeast cell according to claim 4 under conditions suitable for sterol production. 11. A process for production of a sterol mix, comprising cultivating the yeast cell according to claim 6 under conditions suitable for sterol production, wherein (a) ERG5 and ERG6 are inactivated in the yeast cell, (b) the heterologous sterol Δ24-reductase is a vertebrate sterol Δ24-reductase, and (c) the heterologous C5-sterol desaturase is from Pichia pastoris, Penicillium roqueforti, Schizosaccharomyces pombe , or Saccharomyces cerevisiae. 12. The cholesterol-producing yeast cell according to claim 1 , wherein (a) the heterologous C5-sterol desaturase is from Pichia pastoris, Penicillium roqueforti, Schizosaccharomyces pombe , or Saccharomyces cerevisiae, (b) ERG5 and ERG6 are inactivated in the yeast cell, and (c) the yeast cell expresses a heterologous vertebrate sterol Δ24-reductase. 13. A process for production of a sterol mix comprising cultivating the yeast cell according to claim 12 under conditions suitable for sterol production.

Assignees

Inventors

Classifications

  • acting on paired donors with incorporation of molecular oxygen (1.14) · CPC title

  • Fungi {; Processes using fungi} · CPC title

  • Yeast isolates · CPC title

  • C12P33/02Primary

    Dehydrogenating; Dehydroxylating · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12018309B2 cover?
The present invention is related to an improved method for production of 7-dehydrocholesterol (7-DHC), an important intermediate towards biotechnological production of vitamin D3 or derivatives/metabolites thereof. The invention features modified host strains expressing enzymes having improved C-5 sterol 5 desaturase activity and their use in a process for production of vitamin D3 or derivative…
Who is the assignee on this patent?
Dsm Ip Assets Bv
What technology area does this patent fall under?
Primary CPC classification C12P33/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).